Anvisa prioritizes registration of dengue devices

Anvisa prioritizes registration of dengue devices

At the public meeting, Brazil’s National Health Surveillance Agency (Anvisa) announced an urgent decision: it will prioritize all applications for registration of dengue diagnostic devices. The aim is to guarantee effective means for early diagnosis and a faster response in controlling the epidemic. Read more here

If you need more information about regulatory issues in the pharmaceutical industry and healthcare, ELS can certainly help.

Please do not hesitate to contact your local ELS consultant or via email info@elssolutions.pt

ELS Group

ELS Group brings together a team of highly specialized professionals with proven experience in regulatory frameworks and compliance in the pharmaceutical field.

Strategic consulting for the pharmaceutical, healthcare, food, and medtech industries.

Rely on experts to support your regulatory decisions and accelerate the growth of your products safely and efficiently.

Strategic consulting for the pharmaceutical, healthcare, food, and medtech industries.

Experts in pharmaceutical consulting, regulatory strategy, and market access to support your company with safety, compliance, and efficiency. Talk to a consultant.